Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: Implications for reactive oxygen species

Pharmacological Reports

Volumn 61, Issue 1, 2009, Pages 99-104

  Bagi, Zsolt ^a,b   Feher, Attila ^b   Beleznai, Timea ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Antioxidant; Arteriole; Coronary; Diabetes; H2O2

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; GUANYLATE CYCLASE; HYDROGEN PEROXIDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; RETINOL;

ARTERIOLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY VASCULAR RESISTANCE; DIABETIC ANGIOPATHY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SOLID TUMOR; VASODILATATION;

EID: 66949134905     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70011-8     Document Type: Conference Paper

References (58)

1. Bagi Z, Koller A: Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin. J Vasc Res, 2003, 40, 47-57.
2. Bagi Z, Toth E, Koller A, Kaley G: Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH(4). Am J Physiol Heart Circ Physiol, 2004, 287, H626-633.
3. Bauersachs J, Bouloumie A, Fraccarollo D, Hu K, Busse R, Ertl G: Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation, 1999, 100, 292-298.
4. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA, 2002, 287, 2570-2581.
5. Bohlen HG, Lash JM: Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am J Physiol, 1993, 265, H219-225.
6. Brandes RP, Kim D, Schmitz-Winnenthal FH, Amidi M, Gödecke A, Mülsch A, Busse R: Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knock-out mice: role of soluble guanylyl cyclase. Hypertension, 2000, 35, 231-236.
7. Burke TM, Wolin MS: Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol, 1987, 252, H721-732.
8. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res, 2000, 87, 840-844.
9. Camici PG, Crea F: Coronary microvascular dysfunction. N Engl J Med, 2007, 356, 830-840.
10. Cannon RO, 3rd, Camici PG, Epstein SE: Pathophysiological dilemma of syndrome X. Circulation, 1992, 85, 883-892.
11. Cersosimo E, DeFronzo RA: Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev, 2006, 22, 423-436.
12. Creager MA, Luscher TF, Cosentino F, Beckman JA: Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation, 2003, 108, 1527-1532.
13. Cseko C, Bagi Z, Koller A: Biphasic effect of hydrogen peroxide on skeletal muscle arteriolar tone via activation of endothelial and smooth muscle signaling pathways. J Appl Physiol, 2004, 97, 1130-1137.
14. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM: Endothelial dysfunction in diabetes. Br J Pharmacol, 2000, 130, 963-974.
15. 2 increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in Type 2 diabetic mice. Am J Physiol Heart Circ Physiol, 2007, 292, H649-656.
16. Erdei N, Tóth A, Pásztor ET, Papp Z, Edes I, Koller A, Bagi Z.: High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion. Am J Physiol Heart Circ Physiol, 2006, 291, H2107-2115.
17. Erdos B, Miller AW, Busija DW: Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats. Am J Physiol Heart Circ Physiol, 2002, 282, H2060-2065.
18. Frisbee JC: Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats. Am J Physiol Heart Circ Physiol, 2003, 285, H104-111.
19. Frisbee JC: Obesity, insulin resistance, and microvessel density. Microcirculation, 2007, 14, 289-298.
20. Fujimoto S, Asano T, Sakai M, Sakurai K, Takagi D, Yoshimoto N, Itoh T: Mechanisms of hydrogen peroxide-induced relaxation in rabbit mesenteric small artery. Eur J Pharmacol, 2001, 412, 291-300.
21. Fulop T, Jebelovszki E, Erdei N, Szerafin T, Forster T, Edes I, Koller A, Bagi Z: Adaptation of vasomotor function of human coronary arterioles to the simultaneous presence of obesity and hypertension. Arterioscler Thromb Vasc Biol, 2007, 27, 2348-2354.
22. Gutierrez J, Ballinger SW, Darley-Usmar VM, Landar A: Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res, 2006, 99, 924-932.
23. Hegele RA: Angiotensin-converting enzyme (ACE) inhibition in the secondary prevention of vascular disease: the Heart Outcomes Prevention Evaluation (HOPE) Trial and its substudies. Curr Atheroscler Rep, 2000, 2, 361-362.
24. Henderson KK, Turk JR, Rush JW, Laughlin MH: Endothelial function in coronary arterioles from pigs with early-stage coronary disease induced by high-fat, high-cholesterol diet: effect of exercise. J Appl Physiol, 2004, 97, 1159-1168.
25. Hirai T, Tsuru H, Tanimitsu N, Takumida M, Watanabe H, Yajin K, Sasa M: Effect of hydrogen peroxide on guinea pig nasal mucosa vasculature. Jpn J Pharmacol, 2000, 84, 470-473.
26. Hodnett BL, Hester RL: Regulation of muscle blood flow in obesity. Microcirculation, 2007, 14, 273-288.
27. Jaap AJ, Shore AC, Tooke JE: The influence of hypertension on microvascular blood flow and resistance to flow in the skin of patients with type 2 (non-insulin-dependent) diabetes. Diabet Med, 1994, 11, 883-887.
28. Jebelovszki E, Kiraly C, Erdei N, Feher A, Pasztor ET, Rutkai I, Forster T et al.: High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation. Am J Physiol Heart Circ Physiol, 2008, 294, H2558-2564.
29. Knudson JD, Dincer UD, Bratz IN, Sturek M, Dick GM, Tune JD: Mechanisms of coronary dysfunction in obesity and insulin resistance. Microcirculation, 2007, 14, 317-338.
30. Knudson JD, Rogers PA, Dincer UD, Bratz IN, Araiza AG, Dick GM, Tune JD: Coronary vasomotor reactivity to endothelin-1 in the prediabetic metabolic syndrome. Microcirculation, 2006, 13, 209-218.
31. Kunsch C, Medford RM: Oxidative stress as a regulator of gene expression in the vasculature. Circ Res, 1999, 85, 753-766.
32. Luscher TF, Creager MA, Beckman JA, Cosentino F: Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation, 2003, 108, 1655-1661.
33. Matoba T, Shimokawa H, Morikawa K, Kubota H, Kunihiro I, Urakami-Harasawa L, Mukai L et al.: Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels. Arterioscler Thromb Vasc Biol, 2003, 23, 1224-1230.
34. Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD: Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res, 2003, 92, e31-40.
35. + channels. Circulation, 1999, 99, 3132-3138.
36. Munzel T, Daiber A, Ullrich V, Mulsch A: Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol, 2005, 25, 1551-1557.
37. Nahser PJ, Jr., Brown RE, Oskarsson H, Winniford MD, Rossen JD: Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation, 1995, 91, 635-640.
38. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR: Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes, 1993, 42, 1017-1025.
39. Prakash R, Mintz JD, Stepp DW: Impact of obesity on coronary microvascular function in the Zucker rat. Microcirculation, 2006, 13, 389-396.
40. Rapola JM, Virtamo J, Haukka JK, Heinonen OP, Albanes D, Taylor PR, Huttunen JK: Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial. JAMA, 1996, 275, 693-698.
41. Rapola JM, Virtamo J, Ripatti S, Haukka JK, Huttunen JK, Albanes D, Taylor PR, Heinonen OP: Effects of alpha tocopherol and beta carotene supplements on symptoms, progression, and prognosis of angina pectoris. Heart, 1998, 79, 454-458.
42. Ruderman NB, Williamson JR, Brownlee M: Glucose and diabetic vascular disease. FASEB J, 1992, 6, 2905-2914.
43. Scott WS, Nakayama DK: Sustained nitric oxide exposure decreases soluble guanylate cyclase mRNA and enzyme activity in pulmonary artery smooth muscle. J Surg Res, 1998, 79, 66-70.
44. Sowers JR, Epstein M, Frohlich ED: Diabetes, hypertension, and cardiovascular disease: an update. Hypertension, 2001, 37, 1053-1059.
45. Stepp DW, Belin De Chantemele EJ: Structural remodeling in the limb circulation: impact of obesity and diabetes. Microcirculation, 2007, 14, 311-316.
46. Sun D, Huang A, Mital S, Kichuk MR, Marboe CC, Addonizio LJ, Michler RE et al.: Norepinephrine elicits beta2-receptor-mediated dilation of isolated human coronary arterioles. Circulation, 2002, 106, 550-555.
47. Szerafin T, Erdei N, Fulop T, Pasztor ET, Edes I, Koller A, Bagi Z: Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus. Circ Res, 2006, 99, e12-17.
48. Triggle CR, Ding H, Anderson TJ, Pannirselvam M: The endothelium in health and disease: a discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes. Mol Cell Biochem, 2004, 263, 21-27.
49. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ, 1998, 316, 823-828.
50. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A: High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation, 2003, 108, 1253-1258.
51. Ungvari Z, Csiszar A, Kaminski PM, Wolin MS, Koller A: Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am J Pathol, 2004, 165, 219-226.
52. Virtamo J, Rapola JM, Ripatti S, Heinonen OP, Taylor PR, Albanes D, Huttunen JK: Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med, 1998, 158, 668-675.
53. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ: Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet, 2003, 361, 2017-2023.
54. Willcox BJ, Curb JD, Rodriguez BL: Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies. Am J Cardiol, 2008, 101, 75D-86D.
55. Wolin MS, Burke TM: Hydrogen peroxide elicits activation of bovine pulmonary arterial soluble guanylate cyclase by a mechanism associated with its metabolism by catalase. Biochem Biophys Res Commun, 1987, 143, 20-25.
56. Woodman CR, Turk JR, Rush JW, Laughlin MH: Exercise attenuates the effects of hypercholesterolemia on endothelium-dependent relaxation in coronary arteries from adult female pigs. J Appl Physiol, 2004, 96, 1105-1113.
57. Xiang L, Naik J, Hester RL: Exercise-induced increase in skeletal muscle vasodilatory responses in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol, 2005, 288, R987-991.
58. Zhang C, Hein TW, Wang W, Kuo L: Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function. Circ Res, 2003, 92, 322-329.